Antibody data
- Antibody Data
- Antigen structure
- References [52]
- Comments [0]
- Validations
- Immunohistochemistry [2]
- Blocking/Neutralizing [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF644 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Goat Polyclonal VEGFR2/KDR/Flk-1 Antibody
- Antibody type
- Polyclonal
- Description
- Antigen Affinity-purified. Detects mouse VEGFR2 in direct ELISAs and Western blots. In direct ELISAs, approximately 10% cross-reactivity with recombinant human VEGFR2 is observed and less than 2% cross-reactivity with recombinant mouse (rm) VEGFR1 and rmVEGFR3 is observed.
- Reactivity
- Mouse
- Host
- Goat
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Disrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune Encephalomyelitis.
Endothelial Calcineurin Signaling Restrains Metastatic Outgrowth by Regulating Bmp2.
EphrinB2 regulates VEGFR2 during dendritogenesis and hippocampal circuitry development.
Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia.
Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality.
In utero electroporation induces cell death and alters embryonic microglia morphology and expression signatures in the developing hypothalamus.
Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy.
Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease.
Generation of iPSC-derived limb progenitor-like cells for stimulating phalange regeneration in the adult mouse.
Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.
Cell-matrix signals specify bone endothelial cells during developmental osteogenesis.
Retinoic acid-induced upregulation of miR-219 promotes the differentiation of embryonic stem cells into neural cells.
VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Pdgfrb-Cre targets lymphatic endothelial cells of both venous and non-venous origins.
Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization.
Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation.
Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage.
The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development.
The embryonic mouse hindbrain as a qualitative and quantitative model for studying the molecular and cellular mechanisms of angiogenesis.
The embryonic mouse hindbrain as a qualitative and quantitative model for studying the molecular and cellular mechanisms of angiogenesis.
Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma.
The role of IL-1β in the early tumor cell-induced angiogenic response.
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy.
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.
Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation.
Chronic hydrocephalus-induced hypoxia: increased expression of VEGFR-2+ and blood vessel density in hippocampus.
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.
Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.
Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1-/- embryonic stem cells shows early priming of endothelial precursors.
Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro.
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.
Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue.
Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue.
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.
Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
Duc D, Vigne S, Bernier-Latmani J, Yersin Y, Ruiz F, Gaïa N, Leo S, Lazarevic V, Schrenzel J, Petrova TV, Pot C
Cell reports 2019 Oct 8;29(2):378-390.e4
Cell reports 2019 Oct 8;29(2):378-390.e4
Endothelial Calcineurin Signaling Restrains Metastatic Outgrowth by Regulating Bmp2.
Hendrikx S, Coso S, Prat-Luri B, Wetterwald L, Sabine A, Franco CA, Nassiri S, Zangger N, Gerhardt H, Delorenzi M, Petrova TV
Cell reports 2019 Jan 29;26(5):1227-1241.e6
Cell reports 2019 Jan 29;26(5):1227-1241.e6
EphrinB2 regulates VEGFR2 during dendritogenesis and hippocampal circuitry development.
Harde E, Nicholson L, Furones Cuadrado B, Bissen D, Wigge S, Urban S, Segarra M, Ruiz de Almodóvar C, Acker-Palmer A
eLife 2019 Dec 23;8
eLife 2019 Dec 23;8
Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia.
Sones JL, Merriam AA, Seffens A, Brown-Grant DA, Butler SD, Zhao AM, Xu X, Shawber CJ, Grenier JK, Douglas NC
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018 May;32(5):2574-2586
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2018 May;32(5):2574-2586
Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality.
Kim IK, Kim K, Lee E, Oh DS, Park CS, Park S, Yang JM, Kim JH, Kim HS, Shima DT, Kim JH, Hong SH, Cho YH, Kim YH, Park JB, Koh GY, Ju YS, Lee HK, Lee S, Kim I
The Journal of experimental medicine 2018 Mar 5;215(3):963-983
The Journal of experimental medicine 2018 Mar 5;215(3):963-983
In utero electroporation induces cell death and alters embryonic microglia morphology and expression signatures in the developing hypothalamus.
Rosin JM, Kurrasch DM
Journal of neuroinflammation 2018 Jun 12;15(1):181
Journal of neuroinflammation 2018 Jun 12;15(1):181
Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy.
Choquet C, Nguyen THM, Sicard P, Buttigieg E, Tran TT, Kober F, Varlet I, Sturny R, Costa MW, Harvey RP, Nguyen C, Rihet P, Richard S, Bernard M, Kelly RG, Lalevée N, Miquerol L
PLoS genetics 2018 Jul;14(7):e1007502
PLoS genetics 2018 Jul;14(7):e1007502
Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors.
Drummond CJ, Hanna JA, Garcia MR, Devine DJ, Heyrana AJ, Finkelstein D, Rehg JE, Hatley ME
Cancer cell 2018 Jan 8;33(1):108-124.e5
Cancer cell 2018 Jan 8;33(1):108-124.e5
Endothelial deletion of Ino80 disrupts coronary angiogenesis and causes congenital heart disease.
Rhee S, Chung JI, King DA, D'amato G, Paik DT, Duan A, Chang A, Nagelberg D, Sharma B, Jeong Y, Diehn M, Wu JC, Morrison AJ, Red-Horse K
Nature communications 2018 Jan 25;9(1):368
Nature communications 2018 Jan 25;9(1):368
Generation of iPSC-derived limb progenitor-like cells for stimulating phalange regeneration in the adult mouse.
Chen Y, Xu H, Lin G
Cell discovery 2017;3:17046
Cell discovery 2017;3:17046
Impaired angiopoietin/Tie2 signaling compromises Schlemm's canal integrity and induces glaucoma.
Kim J, Park DY, Bae H, Park DY, Kim D, Lee CK, Song S, Chung TY, Lim DH, Kubota Y, Hong YK, He Y, Augustin HG, Oliver G, Koh GY
The Journal of clinical investigation 2017 Oct 2;127(10):3877-3896
The Journal of clinical investigation 2017 Oct 2;127(10):3877-3896
Cell-matrix signals specify bone endothelial cells during developmental osteogenesis.
Langen UH, Pitulescu ME, Kim JM, Enriquez-Gasca R, Sivaraj KK, Kusumbe AP, Singh A, Di Russo J, Bixel MG, Zhou B, Sorokin L, Vaquerizas JM, Adams RH
Nature cell biology 2017 Mar;19(3):189-201
Nature cell biology 2017 Mar;19(3):189-201
Retinoic acid-induced upregulation of miR-219 promotes the differentiation of embryonic stem cells into neural cells.
Wu H, Zhao J, Fu B, Yin S, Song C, Zhang J, Zhao S, Zhang Y
Cell death & disease 2017 Jul 27;8(7):e2953
Cell death & disease 2017 Jul 27;8(7):e2953
VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K, Karaman S, D'Amico G, Tammela T, Sormunen R, Eklund L, Alitalo K, Zarkada G
Circulation research 2017 Apr 28;120(9):1414-1425
Circulation research 2017 Apr 28;120(9):1414-1425
Pdgfrb-Cre targets lymphatic endothelial cells of both venous and non-venous origins.
Ulvmar MH, Martinez-Corral I, Stanczuk L, Mäkinen T
Genesis (New York, N.Y. : 2000) 2016 Jun;54(6):350-8
Genesis (New York, N.Y. : 2000) 2016 Jun;54(6):350-8
Slit2 signaling through Robo1 and Robo2 is required for retinal neovascularization.
Rama N, Dubrac A, Mathivet T, Ní Chárthaigh RA, Genet G, Cristofaro B, Pibouin-Fragner L, Ma L, Eichmann A, Chédotal A
Nature medicine 2015 May;21(5):483-91
Nature medicine 2015 May;21(5):483-91
Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation.
Plein A, Calmont A, Fantin A, Denti L, Anderson NA, Scambler PJ, Ruhrberg C
The Journal of clinical investigation 2015 Jul 1;125(7):2661-76
The Journal of clinical investigation 2015 Jul 1;125(7):2661-76
Semaphorin3A elevates vascular permeability and contributes to cerebral ischemia-induced brain damage.
Hou ST, Nilchi L, Li X, Gangaraju S, Jiang SX, Aylsworth A, Monette R, Slinn J
Scientific reports 2015 Jan 20;5:7890
Scientific reports 2015 Jan 20;5:7890
The Schlemm's canal is a VEGF-C/VEGFR-3-responsive lymphatic-like vessel.
Aspelund A, Tammela T, Antila S, Nurmi H, Leppänen VM, Zarkada G, Stanczuk L, Francois M, Mäkinen T, Saharinen P, Immonen I, Alitalo K
The Journal of clinical investigation 2014 Sep;124(9):3975-86
The Journal of clinical investigation 2014 Sep;124(9):3975-86
KDR identifies a conserved human and murine hepatic progenitor and instructs early liver development.
Goldman O, Han S, Sourisseau M, Dziedzic N, Hamou W, Corneo B, D'Souza S, Sato T, Kotton DN, Bissig KD, Kalir T, Jacobs A, Evans T, Evans MJ, Gouon-Evans V
Cell stem cell 2013 Jun 6;12(6):748-60
Cell stem cell 2013 Jun 6;12(6):748-60
The embryonic mouse hindbrain as a qualitative and quantitative model for studying the molecular and cellular mechanisms of angiogenesis.
Fantin A, Vieira JM, Plein A, Maden CH, Ruhrberg C
Nature protocols 2013 Feb;8(2):418-29
Nature protocols 2013 Feb;8(2):418-29
The embryonic mouse hindbrain as a qualitative and quantitative model for studying the molecular and cellular mechanisms of angiogenesis.
Fantin A, Vieira JM, Plein A, Maden CH, Ruhrberg C
Nature protocols 2013 Feb;8(2):418-29
Nature protocols 2013 Feb;8(2):418-29
Lenalidomide inhibits lymphangiogenesis in preclinical models of mantle cell lymphoma.
Song K, Herzog BH, Sheng M, Fu J, McDaniel JM, Chen H, Ruan J, Xia L
Cancer research 2013 Dec 15;73(24):7254-64
Cancer research 2013 Dec 15;73(24):7254-64
The role of IL-1β in the early tumor cell-induced angiogenic response.
Carmi Y, Dotan S, Rider P, Kaplanov I, White MR, Baron R, Abutbul S, Huszar M, Dinarello CA, Apte RN, Voronov E
Journal of immunology (Baltimore, Md. : 1950) 2013 Apr 1;190(7):3500-9
Journal of immunology (Baltimore, Md. : 1950) 2013 Apr 1;190(7):3500-9
Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
Benedito R, Rocha SF, Woeste M, Zamykal M, Radtke F, Casanovas O, Duarte A, Pytowski B, Adams RH
Nature 2012 Mar 18;484(7392):110-4
Nature 2012 Mar 18;484(7392):110-4
VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd.
Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, Sundvold-Gjerstad V, Gustafsson K, Choy WW, Zang G, Quach M, Jansson L, Phillipson M, Abid MR, Spurkland A, Claesson-Welsh L
The Journal of experimental medicine 2012 Jul 2;209(7):1363-77
The Journal of experimental medicine 2012 Jul 2;209(7):1363-77
The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.
Schreurs MP, Houston EM, May V, Cipolla MJ
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012 Jan;26(1):355-62
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2012 Jan;26(1):355-62
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy.
Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S
Nature cell biology 2011 Mar;13(3):215-22
Nature cell biology 2011 Mar;13(3):215-22
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.
Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A
Nature 2010 May 27;465(7297):487-91
Nature 2010 May 27;465(7297):487-91
Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation.
Fernandez L, Rodriguez S, Huang H, Chora A, Fernandes J, Mumaw C, Cruz E, Pollok K, Cristina F, Price JE, Ferkowicz MJ, Scadden DT, Clauss M, Cardoso AA, Carlesso N
Experimental hematology 2008 May;36(5):545-558
Experimental hematology 2008 May;36(5):545-558
Chronic hydrocephalus-induced hypoxia: increased expression of VEGFR-2+ and blood vessel density in hippocampus.
Dombrowski SM, Deshpande A, Dingwall C, Leichliter A, Leibson Z, Luciano MG
Neuroscience 2008 Mar 18;152(2):346-59
Neuroscience 2008 Mar 18;152(2):346-59
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.
Tammela T, Zarkada G, Wallgard E, Murtomäki A, Suchting S, Wirzenius M, Waltari M, Hellström M, Schomber T, Peltonen R, Freitas C, Duarte A, Isoniemi H, Laakkonen P, Christofori G, Ylä-Herttuala S, Shibuya M, Pytowski B, Eichmann A, Betsholtz C, Alitalo K
Nature 2008 Jul 31;454(7204):656-60
Nature 2008 Jul 31;454(7204):656-60
Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M, Heloterä H, Haiko P, Dumont DJ, Alitalo K
The American journal of pathology 2008 Dec;173(6):1891-901
The American journal of pathology 2008 Dec;173(6):1891-901
Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Depeille P, Young JJ, Boguslawski EA, Berghuis BD, Kort EJ, Resau JH, Frankel AE, Duesbery NS
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Oct 1;13(19):5926-34
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Oct 1;13(19):5926-34
Effects of sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model.
Isayeva T, Chanda D, Kallman L, Eltoum IE, Ponnazhagan S
Cancer research 2007 Jun 15;67(12):5789-97
Cancer research 2007 Jun 15;67(12):5789-97
Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.
Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G, Nagy JA, Dvorak HF, Ylä-Herttuala S, Shibuya M, Alitalo K
The Journal of experimental medicine 2007 Jun 11;204(6):1431-40
The Journal of experimental medicine 2007 Jun 11;204(6):1431-40
Lentiviral rescue of vascular endothelial growth factor receptor-2 expression in flk1-/- embryonic stem cells shows early priming of endothelial precursors.
Li X, Edholm D, Lanner F, Breier G, Farnebo F, Dimberg A, Claesson-Welsh L
Stem cells (Dayton, Ohio) 2007 Dec;25(12):2987-95
Stem cells (Dayton, Ohio) 2007 Dec;25(12):2987-95
Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
Mohamedali KA, Poblenz AT, Sikes CR, Navone NM, Thorpe PE, Darnay BG, Rosenblum MG
Cancer research 2006 Nov 15;66(22):10919-28
Cancer research 2006 Nov 15;66(22):10919-28
Antagonists to human and mouse vascular endothelial growth factor receptor 2 generated by directed protein evolution in vitro.
Getmanova EV, Chen Y, Bloom L, Gokemeijer J, Shamah S, Warikoo V, Wang J, Ling V, Sun L
Chemistry & biology 2006 May;13(5):549-56
Chemistry & biology 2006 May;13(5):549-56
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A.
Nozaki M, Sakurai E, Raisler BJ, Baffi JZ, Witta J, Ogura Y, Brekken RA, Sage EH, Ambati BK, Ambati J
The Journal of clinical investigation 2006 Feb;116(2):422-9
The Journal of clinical investigation 2006 Feb;116(2):422-9
Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2.
Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC, Johns RA
American journal of physiology. Lung cellular and molecular physiology 2006 Dec;291(6):L1159-68
American journal of physiology. Lung cellular and molecular physiology 2006 Dec;291(6):L1159-68
Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C
Gene therapy 2006 Aug;13(16):1198-205
Gene therapy 2006 Aug;13(16):1198-205
Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
Raskopf E, Dzienisowicz C, Hilbert T, Rabe C, Leifeld L, Wernert N, Sauerbruch T, Prieto J, Qian C, Caselmann WH, Schmitz V
Hepatology (Baltimore, Md.) 2005 Jun;41(6):1233-40
Hepatology (Baltimore, Md.) 2005 Jun;41(6):1233-40
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 1;174(1):215-22
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 1;174(1):215-22
Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.
Dikov MM, Ohm JE, Ray N, Tchekneva EE, Burlison J, Moghanaki D, Nadaf S, Carbone DP
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 1;174(1):215-22
Journal of immunology (Baltimore, Md. : 1950) 2005 Jan 1;174(1):215-22
Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue.
Gudehithlu KP, Ahmed N, Wu H, Litbarg NO, Garber SL, Arruda JA, Dunea G, Singh AK
The Journal of laboratory and clinical medicine 2005 Apr;145(4):194-203
The Journal of laboratory and clinical medicine 2005 Apr;145(4):194-203
Antagonism of vascular endothelial growth factor results in microvessel attrition and disorganization of wound tissue.
Gudehithlu KP, Ahmed N, Wu H, Litbarg NO, Garber SL, Arruda JA, Dunea G, Singh AK
The Journal of laboratory and clinical medicine 2005 Apr;145(4):194-203
The Journal of laboratory and clinical medicine 2005 Apr;145(4):194-203
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, Rabizadeh E
Leukemia research 2004 Mar;28(3):243-8
Leukemia research 2004 Mar;28(3):243-8
All three receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells.
Bairey O, Boycov O, Kaganovsky E, Zimra Y, Shaklai M, Rabizadeh E
Leukemia research 2004 Mar;28(3):243-8
Leukemia research 2004 Mar;28(3):243-8
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C
The Journal of cell biology 2003 Jun 23;161(6):1163-77
The Journal of cell biology 2003 Jun 23;161(6):1163-77
Vascular endothelial growth factor-B promotes in vivo angiogenesis.
Silvestre JS, Tamarat R, Ebrahimian TG, Le-Roux A, Clergue M, Emmanuel F, Duriez M, Schwartz B, Branellec D, Lévy BI
Circulation research 2003 Jul 25;93(2):114-23
Circulation research 2003 Jul 25;93(2):114-23
Lack of alpha2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF after acute myocardial infarction.
Matsuno H, Kozawa O, Yoshimi N, Akamatsu S, Hara A, Mori H, Okada K, Ueshima S, Matsuo O, Uematsu T
Blood 2002 Oct 1;100(7):2487-93
Blood 2002 Oct 1;100(7):2487-93
No comments: Submit comment
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- VEGFR2/KDR/Flk-1 in Mouse Embryo. VEGFR2/KDR/Flk-1 in Mouse Embryo.
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- VEGFR2 in Mouse Kidney Tissue. VEGFR2 in Mouse Kidney Tissue.
Supportive validation
- Submitted by
- Novus Biologicals (provider)
- Main image
- Experimental details
- VEGFR2/KDR/Flk-1 Inhibition of VEGF-dependent Cell Proliferation and Neutralization by Mouse VEGFR2/KDR/Flk-1 Antibody. VEGFR2/KDR/Flk-1 Inhibition of VEGF-dependent Cell Proliferation and Neutralization by Mouse VEGFR2/KDR/Flk-1 Antibody.